Structural and functional basis for pan-CoV fusion inhibitors against SARS-CoV-2 and its variants with preclinical evaluation.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Structural and functional basis for pan-CoV fusion inhibitors against SARS-CoV-2 and its variants with preclinical evaluation.
- Published In:
- Signal transduction and targeted therapy, 6(1), 288 (2021)
- Authors:
- Xia, Shuai, Wang, Lijue, Zhu, Yun, Lu, Lu, Jiang, Shibo
- Database ID:
- RPEP-05885
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-05885APA
Xia, Shuai; Wang, Lijue; Zhu, Yun; Lu, Lu; Jiang, Shibo. (2021). Structural and functional basis for pan-CoV fusion inhibitors against SARS-CoV-2 and its variants with preclinical evaluation.. Signal transduction and targeted therapy, 6(1), 288. https://doi.org/10.1038/s41392-021-00712-2
MLA
Xia, Shuai, et al. "Structural and functional basis for pan-CoV fusion inhibitors against SARS-CoV-2 and its variants with preclinical evaluation.." Signal transduction and targeted therapy, 2021. https://doi.org/10.1038/s41392-021-00712-2
RethinkPeptides
RethinkPeptides Research Database. "Structural and functional basis for pan-CoV fusion inhibitor..." RPEP-05885. Retrieved from https://rethinkpeptides.com/research/xia-2021-structural-and-functional-basis-for
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.